• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24114 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Semaglutide 2 mg for type 2 diabetes
2023     National Institute for Health and Care Excellence (NICE) Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal). NICE technology appraisal guidance 910
2023     National Institute for Health and Care Excellence (NICE) Semaglutide for managing overweight and obesity. NICE technology appraisal guidance 875
2005     HAYES, Inc. Semi-implantable electromagnetic hearing aids
2002     HAYES, Inc. Semi-implantable electromagnetic hearing aids
2011     HAYES, Inc. Semi-implantable electromagnetic hearing aids
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Semi-implantable, middle ear hearing aids
2011     HAYES, Inc. Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2013     HAYES, Inc. SensiGene fetal RHD genotyping
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sensimed triggerfish® for 24-hour monitoring of changes in intraocular pressure in glaucoma
2009     NIHR Health Technology Assessment programme Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2014     NIHR Horizon Scanning Centre (NIHR HSC) SensiumVitals® vital signs monitoring patch
2022     NIHR Health Technology Assessment programme Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT
2000     HAYES, Inc. Sensory integration therapy for children with learning disabilities
2004     HAYES, Inc. Sensory integration therapy for children with learning disabilities or developmental delays
2014     HAYES, Inc. Sensory integration therapy for non-autistic children
2003     Wessex Institute for Health Research and Development (WIHRD) Sensory or auditory integration therapy for children with autistic spectrum disorders
2011     HAYES, Inc. Sensory-based treatments for autism spectrum disorders
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) SentiMag and Sienna+ for sentinel lymph node localisation in breast cancer
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2012     NIHR Horizon Scanning Centre (NIHR HSC) SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2006     Medical Services Advisory Committee (MSAC) Sentinel lymph node biopsy in breast cancer
2013     NIHR Health Technology Assessment programme Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2002     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Sentinel node biopsy (SNB) in breast cancer - progress report
2000     ECRI Sentinel node biopsy for staging breast cancer
2001     HAYES, Inc. Sentinel node biopsy for the staging of breast cancer
2005     HAYES, Inc. Sentinel node biopsy for the staging of breast cancer
2019     National Institute for Health and Care Excellence (NICE) Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain. NICE medical technologies guidance 41
2014     Penn Medicine Center for Evidence-based Practice (CEP) Separate instrument sets for prevention of tumor seeding during tumor resection and flap surgery
2008     HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for nonuterine abdominal adhesions
2012     HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012     HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2008     HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for prevention of uterine adhesions
2016     NIHR Health Technology Assessment programme Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation
2016     National Institute for Health and Care Excellence (NICE) SepsiTest assay for rapidly identifying bloodstream bacteria and fungi. NICE diagnostics guidance 20
2012     HAYES, Inc. Septin 9 (SEPT9) methylation analysis for colorectal cancer
2006     National Institute for Health and Care Excellence (NICE) Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome. NICE interventional procedures guidance 199
2014     Penn Medicine Center for Evidence-based Practice (CEP) Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2012     Blue Cross Blue Shield Association (BCBS) Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Sequential antibiotic treatment of pneumonia - primary research
2015     NIHR Horizon Scanning Centre (NIHR HSC) Seralite® for multiple myeloma and other B cell dyscrasias
2012     NIHR Horizon Scanning Centre (NIHR HSC) Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015     NIHR Horizon Scanning Centre (NIHR HSC) Serenity System® to treat tinnitus
2002     Blue Cross Blue Shield Association (BCBS) Serial endpoint testing for the diagnosis and treatment of allergic disorders
2011     HAYES, Inc. Serial Transverse Enteroplasty (STEP) for short bowel syndrome
2007     National Institute for Health and Care Excellence (NICE) Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children. NICE interventional procedures guidance 232
2017     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with HPV vaccination
2019     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with influenza vaccination
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with oral cholera vaccination
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with yellow fever vaccination
2003     HAYES, Inc. Serologic assays for the diagnosis and management of inflammatory bowel disease
2013     HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013     HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2002     Institute for Clinical Systems Improvement (ICSI) Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2006     HAYES, Inc. Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2012     Agency for Healthcare Research and Quality (AHRQ) Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias
2003     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Serum markers of fibrosis and inflammation in chronichepatitis C - systematic review, expert panel
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Serum markers of fibrosis and inflammation in chronichepatitis C - update of previous report
2007     NIHR Horizon Scanning Centre (NIHR HSC) Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2008     Quality Improvement Scotland (NHS QIS ) Service delivery organisation for acute low back pain
2024     NIHR Health Services and Delivery Research programme Service design for children and young people with common mental health problems: literature review, service mapping and collective case study
2003     Adelaide Health Technology Assessment (AHTA) Service improvement tools for the prevention, diagnosis and management of chronic diseases
2024     NIHR Health Services and Delivery Research programme Service innovations for people with multiple long-term conditions: reflections of a rapid evaluation team
2015     NIHR Health Services and Delivery Research programme Service user engagement and health service reconfiguration: a rapid evidence synthesis
2024     National Institute for Health and Care Excellence (NICE) Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome. NICE highly specialised technologies guidance 31
2022     National Institute for Health and Care Excellence (NICE) Setmelanotide for treating obesity caused by LEPR or POMC deficiency. NICE highly specialised technologies guidance 21
2000     Israel Center for Technology Assessment in Health Care (ICTAHC) Setting priorities for the adoption of health technologies on a national level - the Israeli experience
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer in patients with end-stage renal disease: a systematic review and economic evaluation
2012     Institute for Clinical Evaluative Sciences (ICES) Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2013     Health Quality Ontario (HQO) Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Sex change surgery - expert panel. IPE-02/i
2004     HAYES, Inc. Sex reassignment surgery and associated therapies for the treatment of gender identity disorder
2014     HAYES, Inc. Sex reassignment surgery for the treatment of gender dysphoria
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Sexual Assault Nurse Evaluation (SANE) rape crisis procedure: clinical effectiveness and guidelines
2010     Institute of Health Economics (IHE) Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2013     Medical Services Advisory Committee (MSAC) Sexual health medicine consultation items
2015     NIHR Public Health Research (PHR) programme Sexual health promotion for young people delivered via digital media: a scoping review
2004     Agency for Healthcare Research and Quality (AHRQ) Sexuality and reproductive health following spinal cord injury
2022     Agency for Care Effectiveness (ACE) SGLT2 inhibitors for treating heart failure with reduced ejection fraction and chronic kidney disease
1997     VA Technology Assessment Program (VATAP) Shared decision-making programs: a descriptive analysis of experience with shared decision-making programs in VA. A systematic review: assessing the effectiveness of shared decision-making programs for prostate care
2016     Penn Medicine Center for Evidence-based Practice (CEP) Shared governance for nursing assistants and other ancillary medical staff in the hospital setting
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Shared medical appointments (SMAs) for type 2 diabetes management
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2014     NIHR Horizon Scanning Centre (NIHR HSC) Sheffield Support Snood for neurodegenerative conditions
2004     VA Technology Assessment Program (VATAP) Shelf-life of stored sterilized materials: should VHA adopt expiration dating or event-related outdating?
2015     Health Council of the Netherlands Gezondheidsraad (GR) Shiftwork and health risks: possibilities for prevention
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2022     NIHR Health Technology Assessment programme Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022     NIHR Health Technology Assessment programme Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short- and long-term use of benzodiazepines in patients with generalized anxiety disorder: a review of guidelines
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting agents for procedural sedation and analgesia in Canadian emergency departments: a review of clinical outcomes and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2006     National Institute for Health and Care Excellence (NICE) Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery. NICE interventional procedures guidance 177
2013     Health Quality Ontario (HQO) Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review